A Passion for Science and a Commitment to Dermatology Dermavant Sciences is a specialty biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. We are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-in-class therapies that improve patients’ lives. The patient is at the heart of everything we do.
Looking for a particular Dermavant Sciences employee's phone or email?
Dermavant Sciences Questions
The Dermavant Sciences annual revenue was $57.7 million in 2026.
Paul Seaback is the Chief Technical Officer of Dermavant Sciences.
184 people are employed at Dermavant Sciences.
Dermavant Sciences is based in Long Beach, California.
The NAICS codes for Dermavant Sciences are [541, 54, 54138, 5413].
The SIC codes for Dermavant Sciences are [87, 873].
Top Dermavant Sciences Employees
-
Paul Seaback
Chief Technical Officer at Dermavant Sciences
Phoenix, AZ, US24 -
5+5+
-
Kristopher Garcia
VP of Finance at Dermavant Sciences
Newport Beach, CA, US15+ -
Stacie Winter
Director of Global Regulatory Affairs at Dermavant Sciences
Texas, United States35+ -
43
-
24
Related Companies
